No. No GLP-1 drug is approved for cats. Two products are being tested: Okava's OKV-119 implant and Akston's AKS-562c injection. We found no published results from overweight pet cats as of 6 November 2026. Never give a cat a human GLP-1 drug. Ask your vet for a weight plan, which is available now.
What are GLP-1 drugs, and why test them in cats?
GLP-1 drugs are human medicines that act on appetite. Companies are now testing versions for pets, betting that the same idea can help regulate a cat's appetite. These products are only for trials at this point. You can't get one from a vet, a pharmacy or a website, and anything sold online as GLP-1 for cats is not an approved product.
The reason for the interest is simple. Cornell's Feline Health Center quotes an estimate that about half of cats seen in clinics are overweight or obese, and extra weight can worsen arthritis and diabetes.
GLP-1 products are a different group from the peptides this site tracks. BPC-157, TB-500, GHK-Cu and KPV are not GLP-1 drugs and are not in these trials.
Where do OKV-119 and AKS-562c stand?
Both are in early clinical testing in pet cats, and neither is approved. Almost everything public about them comes from the companies or from reports based on what the companies say, so read the table with that in mind.
| Item | OKV-119 (Okava) | AKS-562c (Akston) |
|---|---|---|
| What it is | A small implant placed under the skin at a vet visit. It holds exenatide, a GLP-1 drug. The company says it is designed to last up to six months. | A long-acting GLP-1 injection built on Akston's own protein platform. |
| The trial | MEOW-1, in overweight or obese pet cats. Okava announced the first cat dosed on 2 December 2025. Reports say up to 50 cats, led from the University of Florida. | A Cornell study in overweight or obese pet cats, announced 25 November 2025. Target of 70 cats, with an option for 140, over about 11 weeks. |
| What it measures | Safety, tolerability and weight loss | Weight change and side effects |
| Oversight | Run under an FDA investigational application, per the company | Led by a Cornell vet, sponsored by Akston |
| Published results in overweight pet cats | None found as of 6 November 2026 | None found as of 6 November 2026 |
When might a GLP-1 drug for cats arrive?
Nobody knows, and the dates in circulation disagree. Treat all of the following as company goals or outside estimates. FDA has not announced any approval date.
- Okava's chief executive told ABC News in December 2025 that the company aimed to file for FDA approval between 2027 and 2028. That is a company goal.
- A December 2025 Newsweek report said MEOW-1 results were expected in summer 2026. We found no such results.
- CNBC reported in July 2026 that top-line results from both trials were expected later that year.
- A third-party tracking site with affiliate links says no MEOW-1 results had been published as of October 2026. It estimates results around summer 2027 and availability around 2028 to 2029 at the earliest, if the trials succeed. Those are that site's own estimates, not company or FDA dates.
What have early studies in cats shown?
A little, and only in small groups of healthy lab cats. A 2021 paper on OKV-119 prototypes covered 19 purpose-bred healthy cats. They lost weight while the drug was being released, and the paper reports no implant site reactions and no apparent drug-related harm. Its authors include Okava's chief executive.
At a 2026 veterinary meeting, Akston staff presented a study of 16 healthy young male cats that were not overweight. Food intake fell on AKS-562c, and those cats kept a stable weight while cats in the other groups gained. The study reported no treatment-related toxicity. This was a preclinical study from the company, and those cats did not lose weight.
These results say nothing yet about older, heavier pet cats, about cats with other illnesses, or about long-term use. Okava also says its product could matter for diabetes, kidney disease and longevity. Those are company statements about what might be possible. They are not results.
Why must I never give my cat a human GLP-1 drug?
Because it can be dangerous, and nobody has worked out how to do it safely. That is exactly what the trials are for. Please don't share your own pen, and don't buy a compounded or "research" version for your cat.
- It has happened by accident, and it went badly. Pet Poison Helpline reported a cat given Ozempic in place of insulin. He arrived at an emergency clinic nearly comatose, severely low in blood sugar and dehydrated.
- These drugs reduce appetite, and a cat that eats too little is at risk of fatty liver, which is likely to be fatal without prompt treatment. Cornell warns that even a sudden starvation diet puts a cat at risk of it.
- Pens and doses are made for people. A cat weighs a small fraction of what a person does, and no safe amount of a human GLP-1 drug has been set for cat obesity.
- Cats handle many medicines differently, so results from another species can't be assumed to apply. Our safety guide explains why.
Keep human pens away from your cat
If anyone in your home uses a GLP-1 pen and your cat takes insulin, take care. Pet Poison Helpline warns that these pens can look like some insulin pens, and that they are often kept side by side in the fridge. Store them apart, and go through every medicine with anyone looking after your cat. Pets may also chew pens.
If your cat gets a human GLP-1 drug by mistake, contact a vet or a pet poison line right away. Tiredness, vomiting and a cat that seems very weak or hard to wake are emergencies.
What can a vet do for an overweight cat now?
Quite a lot. First your vet checks whether anything else is going on, then sets a target weight and a measured plan. Cornell's advice is scheduled meals rather than a bowl that is always full, portion control, and a slow loss of roughly 1 to 2% of body weight per week. Canned food can help, since it is mostly water.
Weight matters for comfort too. If your cat has stopped jumping, arthritis may be part of the picture, and treating the pain can help it move more. If your cat is losing weight without trying, that is a different problem and you need this guide instead.
If you would like to know about trials, ask your vet whether one is recruiting near you. Trials have entry rules and your vet can help you weigh them. Everything here is for information only, and it isn't veterinary advice, so talk to a vet about your own cat.
Dutch and Vetster connect you with a licensed vet by video or chat. A cat straining to pee with nothing coming out needs a vet today. Start a vet chat Paid link
Questions cat owners ask
Can I buy Ozempic for my cat?
No, and please don't try. No GLP-1 drug is approved for cats, and no safe amount of a human GLP-1 drug has been set for cat obesity. A cat that eats too little can develop fatty liver, which is a medical emergency. Ask your vet for a weight plan instead.
What is cat Ozempic?
It is a nickname in the news for GLP-1 products being tested in cats, such as Okava's OKV-119 implant. It is not Ozempic, and it is not on sale. The trials are early, and we found no published results from overweight pet cats as of 6 November 2026.
When will GLP-1 for cats be available?
Nobody knows. Okava's stated goal is to file for FDA approval between 2027 and 2028, and an outside tracking site estimates availability around 2028 to 2029 at the earliest. Those are a company goal and a third-party estimate, and both depend on the trials succeeding.
Is OKV-119 safe?
That is what the MEOW-1 trial is measuring. A small early study of healthy lab cats reported no implant site reactions, but its authors include the company's chief executive, and that study can't tell you about overweight pet cats or long-term use.
Are GLP-1 drugs the same as BPC-157?
No. They are different substances. GLP-1 drugs act on appetite and are being tested in cat trials under FDA oversight. BPC-157 has no PubMed results at all for cats, is not officially tested in them and is not FDA-approved for animals.
Sources
- OKAVA Pharmaceuticals, first cat dosed in MEOW-1 (company press release, 2 Dec 2025). Open
- ABC News, Weight loss drugs for cats? (Dec 2025). Open
- Newsweek, MEOW-1 trial starts (Dec 2025). Open
- CNBC, GLP-1 weight-loss drugs are coming for your fat pet (18 Jul 2026). Open
- GLP-1 Pets, trial tracker (third party with affiliate links; its own estimates). Open
- GLP-1 Pets, MEOW-1 results tracker, updated 22 Oct 2026 (third party). Open
- dvm360, Cornell launches clinical trial of GLP-1 therapy for feline weight management (25 Nov 2025). Open
- Cornell University College of Veterinary Medicine, study award for AKS-562c in overweight and obese cats. Open
- dvm360, Investigational drug shows promise for treating feline obesity (18 Jun 2026; Akston study in healthy cats). Open
- Klotsman M et al. Safety, tolerability, and proof-of-concept study of OKV-119 in healthy cats. Front Vet Sci, 2021. Open
- dvm360, Protecting patients from Ozempic exposure (Pet Poison Helpline, Jan 2025). Open
- Cornell Feline Health Center, Obesity. Open
- Cornell Feline Health Center, Hepatic lipidosis. Open